Novel drug for fatal type of heart failure proves safe and effective in phase 3 trial
Pumping over 100,000 times a day, the heart is a critical muscle needed to deliver oxygen and nutrients to our organs to sustain healthy bodily function. Unfortunately, heart failure affects an estimated 6.2 million people in the U.S. and a staggering 64 million worldwide.
Of older patients with heart failure and abnormally thickened hearts, as many as one in five have an underdiagnosed, highly progressive and fatal condition called transthyretin amyloid cardiomyopathy, or ATTR-CM. The disease, which can be hereditary or develop spontaneously, is defined by an accumulation of misfolded transthyretin ...















